GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » EPS without NRI

Lombard Medical Technologies (LSE:LMT) EPS without NRI : £-0.20 (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies EPS without NRI?

Lombard Medical Technologies's earnings per share without non-recurring items for the six months ended in Dec. 2012 was £-0.20. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -21.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -46.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Lombard Medical Technologies's EPS without NRI or its related term are showing as below:

LSE:LMT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72   Med: -50.4   Max: -3.1
Current: -21.2

During the past 10 years, Lombard Medical Technologies's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -3.10% per year. The lowest was -72.00% per year. And the median was -50.40% per year.

LSE:LMT's 3-Year EPS without NRI Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 8.9 vs LSE:LMT: -21.20

Lombard Medical Technologies's EPS (Diluted) for the six months ended in Dec. 2012 was £-0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20.

Lombard Medical Technologies's EPS (Basic) for the six months ended in Dec. 2012 was £-0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20.


Lombard Medical Technologies EPS without NRI Historical Data

The historical data trend for Lombard Medical Technologies's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies EPS without NRI Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.19 -1.79 -0.79 -0.62 -0.41

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.37 -0.81 -0.39 -0.28 -0.20

Competitive Comparison of Lombard Medical Technologies's EPS without NRI

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's PE Ratio without NRI falls into.



Lombard Medical Technologies EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies  (LSE:LMT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lombard Medical Technologies EPS without NRI Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.